Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:40:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Locations section was expanded with numerous new sites across the United States, Argentina, Australia, and various countries in Europe and beyond. Many regional locations were added to reflect broader geographic coverage.
    Difference
    3%
    Check dated 2025-12-23T09:24:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a citation for the 2025 Rheumatology Therapeutics article '196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2' (Dec 2025). Replaced the 'Online ahead of print' note with the finalized 2025 publication details.
    Difference
    0.0%
    Check dated 2025-12-08T22:52:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added publication Gossec L., et al., 'Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naive patients in two phase 3 clinical trials' (Arthritis Res Ther. 2025) and updated the revision to v3.3.2; removed v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:15:18.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added clarifications that publications are provided voluntarily by the study submitter and may be drawn from PubMed, and that entries may not all pertain to the study. Updated the revision version to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:32:15.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:28:51.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.